Alan Berg, M.D.

Southeast Nebraska Cancer CenterLincoln, Nebraska - 68510 (402-327-7363) Cancer Resource Center - LincolnLincoln, Nebraska - 68510 (402-393-3110) Southeast Nebraska Hematology Oncology Consultants ...Lincoln, Nebraska - 68510 (402-420-7000) Southeast Nebraska Hematology & Oncology ...Lincoln, Nebraska - 68510 (402-327-7363) |
- CLINICAL TRIALS 7
- CONDITIONS4
- INTERVENTIONS21
- SINCE2007

Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
May 2007 - June 2015

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
June 2010 - June 2012

Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
December 2008 - June 2010

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Combination Chemotherapy Followed By Docetaxel or Ixabepilone in Treating Patients Who Have Undergone Surgery for Nonmetastatic Breast Cancer
September 2007 - June 2014

Study of ONTAK in Patients With Stage IIIC and Stage IV Melanoma
April 2010 - August 2012

Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
November 2008 - November 2011
Breast Neoplasms
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Melanoma
Placebo
Bavituximab
Paclitaxel
Bevacizumab
Docetaxel
Fluorouracil
Adjuvant Therapy
Cyclophosphamide
Doxorubicin Hydrochloride
Trastuzumab
Lapatinib Ditosylate
Ixabepilone
Ac Regimen
Docetaxel And Vinorelbine
Docetaxel And Carboplatin
Gemcitabine And Docetaxel
Gemcitabine And Carboplatin
Paclitaxel / Carboplatin
Epirubicin Hydrochloride
Ontak (Denileukin Diftitox)
Talactoferrin



